| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $53.4M | +114.4% |
| SG&A Expense | $18.2M | +5.0% |
| Operating Income | -$71.6M | -119.5% |
| Interest Expense | $27K | -96.6% |
| Pre-tax Income | -$71.6M | -119.5% |
| Income Tax | $259K | +222.2% |
| Net Income | -$71.9M | -121.7% |
| EPS (Basic) | -$0.98 | -58.1% |
| EPS (Diluted) | -$0.98 | -58.1% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.7M | -46.4% |
| Current Assets | $71.7M | -45.8% |
| Total Assets | $75.1M | -44.4% |
| Current Liabilities | $13.0M | +19.9% |
| Total Liabilities | $14.7M | +25.1% |
| Stockholders' Equity | $60.3M | -51.1% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.3M | -29.5% |
| Investing Cash Flow | $3.6M | -70.5% |
| Financing Cash Flow | $1.4M | -98.0% |